gut.bmj5d
Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies
Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, carrying a greater risk of developing cirrhosis and its ...
gut.bmj6d
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
Immune checkpoint inhibitors (ICI) have led to breakthrough improvements in the management of malignancy including hepatocellular (HCC) and biliary tract cancer, improving decades-old standards of ...
gut.bmj20d
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
Background Over a century ago, Virchow proposed that cancer represents a chronically inflamed, poorly healing wound. Normal wound healing is represented by a transitory phase of inflammation, followed ...
gut.bmj6d
Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2
Correspondence to Dr Susan M Farrington, CRUK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, Edinburgh, UK; susan.farrington{at}ed.ac.uk Objective ...
gut.bmj3d
Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care
Correspondence to Professor Alexander C Ford, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds LS9 7TF, West Yorkshire, UK; alexf12399{at}yahoo.com Objectives Despite ...
gut.bmj8d
Impairment of spermatogenesis and sperm motility by the high-fat diet-induced dysbiosis of gut microbes
Objective High-fat diet (HFD)-induced metabolic disorders can lead to impaired sperm production. We aim to investigate if HFD-induced gut microbiota dysbiosis can functionally influence ...
gut.bmj7d
Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites
Correspondence to Professor Jun Yu, Institute of Digestive Disease, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; ...
gut.bmj3d
Developments and controversies in the management of oesophageal and gastric varices
2 Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic-IDIBAPS and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain Correspondence to ...
gut.bmj2d
O27 Life cycle analysis – single use scopes vs. reusable scopes: a framework for sustainable endoscopy
Introduction This paper quantifies the environment impact of single use (disposable) endoscopes compared to reusable scopes. Recently there has been a rising interest in disposable scopes to reduce ...
gut.bmj8d
Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19
2 Institute of Clinical and Molecular Virology & Deutsches Zentrum für Immuntherapie (DZI), University of Erlangen-Nürnberg, Erlangen, Germany Contributors All authors drafted the manuscript and ...
gut.bmj3d
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans
a Department of Research and Division of Gastroenterology, University Hospital, CH-4031 Basel, Switzerland, b Rotta Research Laboratorium SpA, I-20052 Monza, Italy Dr Christoph Beglinger, Division of ...
gut.bmj9d
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease
Correspondence to Professor Rohit Loomba, Department of Medicine, University of California San Diego, La Jolla CA 92037, USA; roloomba{at}ucsd.edu Objective Emerging data suggest that a 30% relative ...